Abstract
Background: Eczema affects around 20% of children, but multiple different outcome measures have hampered research into the effectiveness of different treatments. Objectives: To compare the change in scores and correlations within and between five measures of eczema severity: Patient-Orientated Eczema Measure (POEM), Eczema Area and Severity Index (EASI), Six Area, Six Sign Atopic Dermatitis (SASSAD), Three Item Severity (TIS) and skin hydration (corneometry). Methods: Data from a feasibility trial that randomized young children with eczema to one of four emollients were used. Participants were followed for 3 months (84 days). Descriptive statistics (by emollient over time) and Spearman's correlation coefficients comparing scores at each time point and absolute change (between adjacent time points) for each outcome measure were calculated. Results: In total, 197 children, mean ± SD age 21·7 ± 12·8 months, were randomized. POEM and TIS appeared to capture a range of eczema severity at baseline, but only POEM had close approximation to normal distribution. Mean POEM, EASI, SASSAD and TIS scores improved month by month, with POEM showing the greatest sensitivity (effect size 0·42). Correlations within POEM, EASI, SASSAD and TIS were moderate to good, decreasing over time. Correlations between measures were strongest for EASI, SASSAD and TIS. By contrast, corneometry scores were more variable, correlated less well over time and were poorly correlated with the other measures. Conclusions: Except for corneometry, all measures appear to change in relation to emollient use over time and correlate well with themselves. POEM demonstrated the greatest range of scores at baseline and change in eczema severity over the first 28 days.
Original language | English |
---|---|
Pages (from-to) | 362-370 |
Number of pages | 9 |
Journal | British Journal of Dermatology |
Volume | 179 |
Issue number | 2 |
Early online date | 24 Feb 2018 |
DOIs | |
Publication status | Published - 1 Aug 2018 |
Funding
The COMET study was independent research funded by the National Institute for Health Research (NIHR; Research for Patient Benefit Programme, PB-PG-0712-28056). M.J.R. was funded during the study by the NIHR (Clinical Trials Fellowship CTF-01-12-06 and Post-Doctoral Fellowship PDF-2014-07-013). N.M.R. is supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health. We would like to thank all the children, parents and surgeries who took part in the original study and the members of the joint Trial Steering/Data Monitoring Committee (TS/DM-C). COMET was designed and delivered in collaboration with the Bristol Randomised Trials Collaboration (a UKCRC Registered Clinical Trials Unit in receipt of National Institute for Health Research CTU support funding) and the sponsor, the University of Bristol.
ASJC Scopus subject areas
- Dermatology